20 results

• Gilenya Birth Defect Risk Results in Pregnancy Warning in Canada

  December 23, 2019

  Irvin Jackson

  Canadian health officials warn that use of Gilenya has been linked to an increased risk of congenital malformations in newborms when taken by pregnant women.

• Side Effects of Rituxan for MS Treatment May Carry Increased Infection Risks: Study

  October 15, 2019

  Martha Garcia

  Some newer MS drugs increase the risk of infection, according to the findings of a new study.

• Stopping Gilenya May Worsen Multiple Sclerosis, FDA Warns

  November 21, 2018

  Martha Garcia

  The FDA has issued a new Gilenya warning, indicating that halting treatment of the MS drug can result in worsening symptoms and disability.

• Gilenya Fails To Slow Primary Progressive Multiple Sclerosis: Study

  March 21, 2016

  Irvin Jackson

  A new clinical trial reveals that the MS drug Gilenya is ineffective in treating primary progressive multiple sclerosis.

• Gilenya Brain Infection Problems Lead To FDA Warning Label Update

  August 5, 2015

  Irvin Jackson

  The FDA warns that Gilenya has been linked to two cases of a deadly brain infection in multiple sclerosis patients who have taken no other immunosuppressant drugs.

• Study Links Gilenya Side Effects to Low White Blood Cell Count

  December 31, 2014

  Irvin Jackson

  A new study suggests that the MS drug Gilenya lowers the level of some white blood cells, reducing the effectiveness of the body's immune system.

• Gilenya Side Effects Evaluated in ISMP Report

  October 3, 2014

  Irvin Jackson

  A new report shows a high rate of side effects linked to the MS drug Gilenya, raising questions about its rapid approval.

• Jakafi Risks Require Monitoring of Dose During First Three Months: Study

  December 30, 2013

  Irvin Jackson

  Doctors should closely monitor Jakafi patients for the first three months for signs of anemia, according to a new study.

• Tecfidera and Death of Patient Likely Unrelated: Biogen

  July 23, 2013

  Irvin Jackson

  Biogen says it is investigating the death of a woman who took the new multiple sclerosis drug Tecfidera, but does not expect to find a link.

• DOJ Launches Novartis Probe Into Gilenya Illegal Marketing

  July 19, 2013

  Irvin Jackson

  The Justice Department is investigating Novartis over potential kickbacks related to sales of Gilenya.